enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. 5 Supplements You Shouldn’t Take If You’re Taking a GLP-1 ...

    www.aol.com/lifestyle/5-supplements-shouldn-t...

    Discover which supplements may worsen GLP-1 medications’ side effects.

  3. Do ‘Natural GLP-1 Supplements’ Actually Work As Well As ...

    www.aol.com/natural-glp-1-supplements-actually...

    To explain a natural GLP-1 supplement, it’s important to first go over what a GLP-1 receptor agonist is. One of the most popular GLP-1 receptor agonists is Ozempic, a semaglutide medication that ...

  4. Are GLP-1 supplements 'nature's Ozempic'? Doctors evaluate ...

    www.aol.com/news/glp-1-supplements-natures...

    GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help people lose weight and are safe.

  5. GLP1 poly-agonist peptides - Wikipedia

    en.wikipedia.org/wiki/GLP1_poly-agonist_peptides

    GLP1 poly-agonist peptides [1] are a class of drugs that activate multiple peptide hormone receptors including the glucagon-like peptide-1 (GLP-1) receptor.These drugs are developed for the same indications as GLP-1 receptor agonists—especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

  6. Aleniglipron - Wikipedia

    en.wikipedia.org/wiki/Aleniglipron

    Aleniglipron (development code GSBR-1290) is a small-molecule GLP-1 agonist developed by Structure Therapeutics. [1] It is delivered orally and is in a Phase II trial as of 2023.

  7. Taspoglutide - Wikipedia

    en.wikipedia.org/wiki/Taspoglutide

    Taspoglutide is a former experimental drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), that was under investigation for treatment of type 2 diabetes and being codeveloped by Ipsen and Roche. [1] [2] Initially, phase II trials reported it was effective and well tolerated. [3]

  8. GLP-1 drugs linked to lower dementia risk, higher risk of ...

    www.aol.com/glp-1-drugs-linked-lower-150000525.html

    A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.

  9. Glucagon-like peptide-1 - Wikipedia

    en.wikipedia.org/wiki/Glucagon-like_peptide-1

    The initial product GLP-1 (1–37) is susceptible to amidation and proteolytic cleavage, which gives rise to the two truncated and equipotent biologically active forms, GLP-1 (7–36) amide and GLP-1 (7–37). Active GLP-1 protein secondary structure includes two α-helices from amino acid position 13–20 and 24–35 separated by a linker region.